IMM 1.41% 35.0¢ immutep limited

Ann: Final Phase IIb AIPAC clinical trial results for Efti in MBC, page-27

  1. 655 Posts.
    lightbulb Created with Sketch. 47
    Immutep was up 11% on Nasdaq ,it’s created a big gap on graph and quite oversold considering the news was good if not great
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.